Bridging the gap to translation by understadning and preventing diabetic vascular complications using human organoid culture (MRC NPI: David Andrew Long)

通过使用人类类器官培养了解和预防糖尿病血管并发症来缩小翻译差距（MRC NPI：David Andrew Long）

• 批准号: 410862
• 负责人: Penninger Josef
• 金额: $ 32.72万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-09-01 至 2022-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=410862&lang=en
• 关键词: Albuminuria; Angiopoietin-2 Blockade; Apelin Blockade; Blood Vessel Damage Protective Factors; Blood Vessel Organoids; Diabetes; Diabetic Nephropathy; Diabetic Vasculopathy

Diabetes affects 3.0 Million Canadians. Globally 8.8% of the population is affected by this disease and this number is rising due to an aging population and increasing obesity. In Canada, the cost of treating new cases of diabetes diagnosed from 2012-22 i

300万加拿大人患有糖尿病。全球8.8%的人口受到这种疾病的影响，由于人口老龄化和肥胖的增加，这一数字正在上升。在加拿大，从2012年到2022年，治疗新诊断的糖尿病病例的费用为1%